|Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy|
L Apetoh, F Ghiringhelli, A Tesniere, M Obeid, C Ortiz, A Criollo, G Mignot, ...
Nature medicine 13 (9), 1050, 2007
|70-gene signature as an aid to treatment decisions in early-stage breast cancer|
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
|Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation|
M Robson, SA Im, E Senkus, B Xu, SM Domchek, N Masuda, S Delaloge, ...
New England Journal of Medicine 377 (6), 523-533, 2017
|The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy|
L Apetoh, F Ghiringhelli, A Tesniere, A Criollo, C Ortiz, R Lidereau, ...
Immunological reviews 220 (1), 47-59, 2007
|Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy|
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301, 2014
|Breast cancer with synchronous metastases: trends in survival during a 14-year period|
F Andre, K Slimane, T Bachelot, A Dunant, M Namer, A Barrelier, ...
Journal of Clinical Oncology 22 (16), 3302-3308, 2004
|Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized …|
JY Pierga, FC Bidard, C Mathiot, E Brain, S Delaloge, S Giachetti, ...
Clinical Cancer Research 14 (21), 7004-7010, 2008
|Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array|
F Andre, B Job, P Dessen, A Tordai, S Michiels, C Liedtke, C Richon, ...
Clinical Cancer Research 15 (2), 441-451, 2009
|Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study|
MV Dieci, C Criscitiello, A Goubar, G Viale, P Conte, V Guarneri, G Ficarra, ...
Annals of oncology 25 (3), 611-618, 2014
|Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 …|
A Chan, S Delaloge, FA Holmes, B Moy, H Iwata, VJ Harvey, NJ Robert, ...
The Lancet Oncology 17 (3), 367-377, 2016
|Incidence and predictors of drug-eluting stent fracture in human coronary artery: a pathologic analysis|
G Nakazawa, AV Finn, M Vorpahl, E Ladich, R Kutys, I Balazs, ...
Journal of the American College of Cardiology 54 (21), 1924-1931, 2009
|Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer|
R Rouzier, L Pusztai, S Delaloge, AM Gonzalez-Angulo, F Andre, ...
Journal of Clinical Oncology 23 (33), 8331-8339, 2005
|High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for …|
JY Pierga, D Hajage, T Bachelot, S Delaloge, E Brain, M Campone, ...
Annals of oncology 23 (3), 618-624, 2011
|Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer|
FC Bidard, C Mathiot, S Delaloge, E Brain, S Giachetti, P De Cremoux, ...
Annals of Oncology 21 (4), 729-733, 2009
|The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer|
F Cardoso, S Loibl, O Pagani, A Graziottin, P Panizza, L Martincich, ...
European journal of cancer 48 (18), 3355-3377, 2012
|Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer|
F Andre, N Cabioglu, H Assi, JC Sabourin, S Delaloge, A Sahin, K Broglio, ...
Annals of oncology 17 (6), 945-951, 2006
|First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study|
J Bergh, IM Bondarenko, MR Lichinitser, A Liljegren, R Greil, NL Voytko, ...
J Clin Oncol 30 (9), 921-929, 2012
|Genomic index of sensitivity to endocrine therapy for breast cancer|
WF Symmans, C Hatzis, C Sotiriou, F Andre, F Peintinger, P Regitnig, ...
Journal of clinical oncology 28 (27), 4111, 2010
|Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors|
A Carpentier, RJ McNichols, RJ Stafford, J Itzcovitz, JP Guichard, ...
Operative Neurosurgery 63 (suppl_1), ONS21-ONS29, 2008
|Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients—preliminary evidence of activity|
S Delaloge, A Yovine, A Taamma, M Riofrio, E Brain, E Raymond, P Cottu, ...
Journal of Clinical Oncology 19 (5), 1248-1255, 2001